Arabian International Medical Holding Company (Tibah), a leading healthcare company in the Kingdom of Saudi Arabia, announced a strategic leadership change aimed at strengthening its future trajectory. In an official statement published on the Saudi Stock Exchange (Tadawul), the company revealed that it will not be renewing the contract of its current CEO, Mr. Christophe Yvonne Lala, by mutual agreement, effective February 28, 2026.
Background and context of change
This change comes at a time when the Saudi healthcare sector is undergoing a radical and unprecedented transformation, driven by the Health Sector Transformation Program within the Kingdom’s Vision 2030. This ambitious vision aims to restructure the sector, enhance private sector participation, and raise the quality and efficiency of healthcare services provided to citizens and residents. In this context, companies like “Tibbiyah” are striving to align their strategies with national objectives and capitalize on the tremendous opportunities presented by this transformation, including expanding services, adopting modern technologies, and focusing on innovative care models.
Appointing new leadership to keep pace with the future
Based on the approval of the Board of Directors and the recommendation of the Nominations and Remuneration Committee, the company decided to appoint Mr. Mohamed Mostafa as the new Chief Executive Officer, to officially begin his duties on March 1, 2026. Mr. Mostafa is expected to play a pivotal role in leading the company during the next phase, which requires a strategic vision capable of adapting to the rapidly changing market.
The importance of the new role and its expected impact
The new CEO's responsibilities will include overseeing the company's ongoing transformation, supporting organic growth initiatives by expanding existing services, and evaluating and implementing inorganic growth opportunities such as acquisitions and strategic partnerships. He will also be responsible for fostering a culture of innovation within the company, particularly in the areas of digital health and innovative healthcare solutions, which are crucial to the future of healthcare both globally and locally. This appointment is expected to enhance Tibiyah's competitive position in the Saudi market, making it a more influential player regionally and internationally, and attracting further investments and high-quality partnerships.
Strengthening corporate governance
In a related development, “Tibbiyah” announced the extension of the nomination period for its Board of Directors for the upcoming term until February 8, 2026. The company invited shareholders wishing to nominate themselves or others who meet the requirements to submit their applications electronically via the Nominations and Remuneration Committee's email address: [email protected] The company emphasized the importance of adhering to the specified procedure to ensure the review of all applications, stressing that the committee will not consider any applications submitted through other channels.
